These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1549873)
1. The influence of RS-61443 on antibody-mediated rejection. Knechtle SJ; Wang J; Burlingham WJ; Beeskau M; Subramanian R; Sollinger HW Transplantation; 1992 Mar; 53(3):699-701. PubMed ID: 1549873 [No Abstract] [Full Text] [Related]
2. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467 [No Abstract] [Full Text] [Related]
3. Enhancement of allograft survival by combination RS-61443 and DUP-785 therapy. Kawamura T; Hullett DA; Suzuki Y; Bechstein WO; Allison AM; Sollinger HW Transplantation; 1993 Apr; 55(4):691-4; discussion 694-5. PubMed ID: 8475537 [TBL] [Abstract][Full Text] [Related]
4. Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection. D'Alessandro AM; Rankin MA Transplant Proc; 1994 Jun; 26(3):1611-2. PubMed ID: 8030056 [No Abstract] [Full Text] [Related]
5. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785). Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444 [No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model. Klupp J; van Gelder T; Dambrin C; Regieli J; Boeke K; Billingham ME; Morris RE Transplant Proc; 2001 May; 33(3):2170-1. PubMed ID: 11377490 [No Abstract] [Full Text] [Related]
7. Effect of brequinar sodium on in vivo antibody production. Yasunaga C; Cramer DV; Cosenza CA; Tuso PJ; Chapman FA; Barnett M; Wu GD; Putnam BA; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):40-4. PubMed ID: 8516942 [No Abstract] [Full Text] [Related]
8. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Morris RE; Wang J; Blum JR; Flavin T; Murphy MP; Almquist SJ; Chu N; Tam YL; Kaloostian M; Allison AC Transplant Proc; 1991 Apr; 23(2 Suppl 2):19-25. PubMed ID: 2063417 [No Abstract] [Full Text] [Related]
9. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium. Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948 [No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat. Chen H; Qi S; Xu D; Wu J; Busque S; Daloze P Transplant Proc; 1998 Jun; 30(4):1049-50. PubMed ID: 9636424 [No Abstract] [Full Text] [Related]
11. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro. Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631 [No Abstract] [Full Text] [Related]
13. Effect of major histocompatibility disparity on mycophenolate mofetil immunosuppression in rat pancreas transplantation. Schulak JA; Krishnamurthi V; Masih R; Robinson A Transplant Proc; 1995 Dec; 27(6):3010-1. PubMed ID: 8539816 [No Abstract] [Full Text] [Related]